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Evaluation of the treatment results of laryngeal carcinoma:
our experience over 10 years
Erkan KARATAŞ1, Elif BAYSAL2, Cengiz DURUCU2, Tekin BAĞLAM3, Yıldırım Ahmet BAYAZIT4,
Muzaffer KANLIKAMA2
Aim: To retrospectively analyze the treatment results for laryngeal carcinoma and to find the impact of the clinical
parameters on the survival of the patients.
Materials and methods: The medical records of 150 consecutive patients, operated on for laryngeal squamous cell
carcinoma between 1991 and 2009, were reviewed. Tumor localization, TNM stages, treatment modalities, radiotherapy,
second primary tumors, and tumor recurrence were recorded, and the survival data were obtained.
Results: Neck metastasis was rare (3.6%) in T1 and T2 glottic tumors, while there was a significant increase in the rate
of N+ neck (35%) in T3 and T4 glottic tumors (P < 0.05). N+ neck was encountered in 28% of the early and 33% of the
late-stage supraglottic cancers (P > 0.05). There was a significant relation between survival and tumor recurrence (P <
0.05), whereas the other clinical parameters were not associated with survival (P > 0.05). The risk for death of the disease
increased by 63.3% when tumor recurrence occurred (odds ratio = 6.3573).
Conclusion: Aggressive treatment of the primary tumor and neck may eliminate the impact of advanced tumor stage
on survival. Local and regional recurrence and second primary diagnosis are the most important factors involved in
survival in laryngeal carcinoma.
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Introduction
Laryngeal carcinoma is one of the most frequently
encountered cancers in the practice of otolaryngology.
Although its treatment has been established, an
improvement in the survival rates is warranted. The
main therapeutic dilemma occurs when a patient
presents with an N0 neck that may potentially harbor
an occult metastatic disease (1). Management of N0
neck is advocated when the possibility of occult neck
metastasis is greater than 20% (2), although this issue
is debated.
In our practice, the treatment is mainly surgical
and is combined with postoperative radiotherapy
when indicated. We do not perform induction

chemotherapy. We usually perform total laryngectomy
in advanced tumors (T3 and T4) and partial surgery
in early-stage tumors. The management of N0 neck
is performed as follows: watchful waiting in earlystage glottic cancer, ipsilateral neck dissection
and watchful waiting for the contralateral neck in
advanced glottic cancer, and bilateral neck dissection
in supraglottic tumors. Neck dissection is elective,
selective, or modified radical, depending upon the
clinical judgment. N+ neck is treated with radical or
modified radical type I dissection. We recommend
postoperative radiotherapy when there is metastasis
in at least one of the cervical lymph nodes, or thyroid
cartilage or neurovascular invasion.
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In this study, we aimed to retrospectively analyze
the treatment results of laryngeal carcinoma as well
as to find the impact of the clinical parameters of the
patients on survival.
Materials and methods
The medical records of 150 consecutive patients
who were operated on for laryngeal squamous cell
carcinoma between 1991 and 2009 were reviewed.
All of the patients were treated and followed up with
at the Department of Otolaryngology and Head and
Neck Surgery of a university hospital. Only 2 of the
patients were women. The ages of the patients ranged
from 30 to 87 years (mean: 58.1 years). The minimum
follow-up time was 1 year, and the mean follow-up
time was 4.8 years.
The clinical parameters of the patients (tumor
localization, T and N stages, treatment modalities,
radiotherapy, metastasis, second primary diagnosis,
and tumor recurrence) were recorded. Tumor staging
was made according to clinical examination with
palpation, laryngoscopy, and computed tomography,
unless the patient was operated on. Otherwise, staging
was based on the postoperative histopathological
evaluation. The data regarding the survival of the
patients were obtained according to follow-up results
noted in the patient files, as well as from telephone
interviews with the family members of the patients
(Table 1).
Statistics: SPSS 11.0 for Windows was used to
perform the statistical analyses. The parameters of
the surviving and deceased patients were compared
using one-way ANOVA. The impact of the clinical
parameters on survival was evaluated using Cox
regression analysis. The survival curves were
calculated using the Kaplan–Meier method.
Results
Of the 150 patients, 138 were treated surgically, while
12 patients who had T1 tumors were treated with
radiotherapy. Surgical treatment included partial
and total laryngectomy. Radical, modified radical
(types I, II, or III), or selective neck dissection was
performed accordingly.
All of the patients who underwent total
laryngectomy had either T3 or T4 tumors. Most

of the patients with T2 and T3 supraglottic tumors
underwent supraglottic laryngectomy, while total
laryngectomy was performed in T4 supraglottic
cancers. None of the patients had been irradiated
before surgery, while 22 patients had postoperative
radiotherapy (Table 2).
Neck metastasis was rare (3.6%) in T1 and T2
glottic tumors, while there was a significant increase
in the rate of N+ necks (35%) in T3 and T4 glottic
tumors (P = 0.006). N+ neck was encountered in 28%
of the early and 33% of the late-stage supraglottic
cancers (P > 0.05). Metastasis to the cervical lymph
nodes was also high in T3 and T4 transglottic tumors
(Table 3).
Of the 150 patients, 18 (12%) died in the
postoperative follow-up period. Local, regional,
and peristomal tumor recurrences were observed
in 1 (0.7%), 2 (1.3%), and 4 (2.7%) of the 150
patients, respectively. A second primary tumor
was encountered in 2 (1.3%) patients; 1 was in
the esophagus and 1 was in the lung. These were
metachronous second primaries.
Upon variance analysis, there was no significant
difference between the clinical parameters of the
patients who died and those who survived, except for
tumor recurrence. Cox regression analysis revealed
that there was a significant relation between survival
and tumor recurrence (r = 0.183, df = 1, P = 0.008),
whereas the other clinical parameters were not
associated with survival (P > 0.05). Recurrence was
an independent prognostic factor. The risk for death
from the disease increased by 63.3% when tumor
recurrence occurred (odds ratio = 6.3573) (Figure).
Discussion
Appropriate management of N0 neck in supraglottic
laryngeal cancer is controversial in head and neck
surgery. The procedure of choice used to be complete
functional neck dissection, removing levels I through
V, with an associated risk of spinal nerve, deep cervical
plexus, and thoracic canal damage (3). However,
aggressive surgical management (bilateral dissection
of levels I through V) can be made in the clinical N0
neck because of the high incidence of occult regional
disease, even in early-stage supraglottic cancer (4). In
a study performed on 41 consecutive patients who
1395
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Table 1. Clinical parameters of the patients with laryngeal carcinoma.

Status
Parameter

Survival
n (%)

Death
n (%)

Localization
Glottic
Supraglottic
Transglottic
Subglottic

42 (31.8)
54 (40.9)
32 (24.2)
4 (3)

6 (33.3)
6 (33.3)
5 (27.8)
1 (5.6)

T stage
T1
T2
T3
T4

19 (14.4)
35 (26.5)
58 (43.9)
20 (15.2)

2 (11.1)
5 (27.8)
5 (27.8)
6 (33.3)

N stage
N0
N1
N2

100 (75.8)
13 (9.8)
19 (14.4)

11 (61.1)
3 (16.7)
4 (22.2)

Treatment
Radiotherapy
Total laryngectomy
Partial laryngectomy

12 (9.1)
84 (63.6)
36 (27.3)

12 (66.7)
6 (33.3)

Tumor recurrence
Present
Absent

3 (2.3)
129 (97.7)

4 (22.2)
14 (77.8)

underwent supraglottic laryngectomy, the overall
tumor-free survival, with a 2-year minimum followup period, was 90%. In the same study, the favorable
results were attributed to frozen section control
of surgical margins, surgical or radiation therapy,
and treatment of cervical lymph nodes at risk for
metastatic disease (5). In our series, N+ neck was
encountered in 28% of the early and 33% of the latestage supraglottic cancers. These patients underwent
bilateral neck dissection. The surgical treatment was
supraglottic laryngectomy in most of the T2 and T3
tumors, and total laryngectomy in the T4 tumors.
Early-stage glottic tumors can be treated with
radiation therapy or partial laryngectomy. In our
series, the neck metastasis rate was 3.6% in T1 and
T2 glottic tumors. In general, neck dissection is
1396

not necessary in early-stage glottic cancers unless
there is a clinically detectable cervical metastasis.
However, treatment of the neck in T3N0 and T4N0
glottic tumors is controversial because of the low risk
of neck metastasis in these cancers, which ranges
from 3% to 30% (6–8). Although the treatment of
N0 neck T3 and T4 glottic cancers is debated, most
otolaryngologists perform neck dissections in these
tumors (6). In T3N0 cancer, regional control is 69%
if the neck nodes are not treated electively, compared
with 98% for the planned combined (surgery and
radiotherapy) treatment group, which necessitates
elective treatment of the neck nodes (9). As suggested
in a study by Kada et al., we also perform neck
dissection in advanced glottic cancers (10). In our
series, 35% of the patients with T3 and T4 glottic
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Table 2. Treatment of the patients with laryngeal carcinoma.
Ipsilateral neck

Contralateral neck

Postoperative radiation
therapy

Total laryngectomy
(n = 96)

RND (n = 91)

RND (n = 27)
MRND (n = 42)

16

Supraglottic laryngectomy
(n = 27)

RND (n = 27)

RND (n = 18)
MRND (n = 9)

6

Vertical laryngectomy
(n = 6)

-

-

-

Cordectomy
(n = 9)

-

-

-

RND (n = 118)

RND (n = 45)
MRND (n = 51)

12

Laryngeal surgery

Total
(n = 138)

RND: Radical neck dissection, MRND: modified radical neck dissection.

tumors had N+ neck. Therefore, we recommend neck
dissection in these tumors.

(13). According to our results, there was no relation
between tumor localization and survival.

It was suggested that administration of
postoperative radiotherapy in patients with surgically
treated laryngeal cancer with histologically proven
positive neck nodes does not change the survival
or local recurrence rates (11). This contention is in
parallel with our results because in our series, we also
irradiated 22 patients who had histopathologically
proven positive neck lymph nodes after surgery, and
the survival and recurrence rates of these patients
were similar with the others.

There are numerous factors suggested to impact
survival, such as tumor localization, advanced tumor
stage, lymph node metastasis, distant metastasis,
peristomal recurrence, cartilage invasion, local
or regional recurrence, surgical margins, and the
site of metastasis (8,14,15). However, locoregional
recurrence appears to be particularly important in
laryngeal cancer. It can be seen in up to 21% of the
patients (16) and was 4.7% in our study. Recurrence
can be seen in different local and regional sites. The
peristomal recurrence rate ranges from 1.8% to
8.7% (16–18) and was 2.7% in our series. In glottic
cancer, survival with no evidence of disease was
chiefly determined by the development of regional
recurrence, distant metastasis, and a new primary
cancer (19). The overall survival rate was 88% in
our series. In supraglottic tumors, the overall 3-year
survival was 83.6%, and there was a significant
difference in the recurrence rate between patients

Transglottic tumors were proposed to have a
poor prognosis regarding survival when compared
to supraglottic tumors (12). It was suggested that in
T3N0 and T3N1 glottic and transglottic carcinoma,
recurrences in the neck were seen in 16.4% of the
patients who underwent surgery and in 10.5% of
those who had radiotherapy. It was suggested that the
5-year overall survival rate was 56.3% in a surgically
treated group and 35.2% in a radiotherapy group

Table 3. Status of the cervical lymph nodes in laryngeal carcinoma.
Tumor

Glottic

Supraglottic

Transglottic

Subglottic

Neck

N0 n (%)

N+ n (%)

N0 n (%)

N+ n (%)

N0 n (%)

N+ n (%)

N0 n (%)

N+ n (%)

T1-2

27 (96.4)

1 (3.6)

21 (72)

8 (28)

1 (100)

-

1 (33.3)

2 (66.6)

T3-4

13 (65)

7 (35)

21 (67)

10 (33)

25 (69.4)

11 (29.6)

2 (100)

-
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Figure. Kaplan-Meier survival graphic in the patients with
recurrence.

with N0 and N+ necks (20). We did not find a
significant correlation between N stage and survival.
In our series, tumor recurrence was the single most

important factor associated with survival. The
risk of mortality of the disease increased by 63.3%
when tumor recurrence occurred. Locoregional
failure is prognostic with a significant decrease in
overall survival (12,21). In a study by Bilici et al.,
it was reported that age, lymph node involvement,
clinical stage, and the extent of surgical margin are
prognostic factors associated with survival time in
gastric cancer (22). Strongin et al. showed in their
study that the primary tumor volume is an important
prognostic factor of local and regional control and
overall survival among patients with squamous cell
carcinoma of the head and neck, which is in parallel
with our findings (23).
In conclusion, aggressive treatment of the
primary tumor and neck may eliminate the impact of
advanced tumor stage on survival. Local and regional
recurrence and second primary diagnosis are the
most important factors associated with survival in
laryngeal carcinoma.
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